Quantitative nodal burden as a predictive marker for chemotherapy benefit in postoperative ampullary adenocarcinoma: a multi-institution population-based study
This study emphasizes the potential of LODDS to inform personalized therapeutic decisions in the management of AA.
Authors
- Zheng Li (ORCID: https://orcid.org/0000-0003-4415-6552)
- Chongyuan Sun
- Dongbing Zhao (ORCID: https://orcid.org/0000-0002-6770-2694)
- Xing Cheng (ORCID: https://orcid.org/0000-0001-9365-9389)
- Fei He (ORCID: https://orcid.org/0000-0003-0542-2686)
- Zefeng Li
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-19
- DOI
- https://doi.org/10.3389/fimmu.2025.1610334
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00